Stay updated on ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC
Sign up to get notified when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.

Latest updates to the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study page now indicates recruitment is closed for participants, and several help/navigation items were added along with a revision/version note updating from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check18 days agoChange DetectedThe page now shows revision v3.5.5, replacing the previous v3.5.4, indicating a new version of the page content. This change reflects an update to the page’s version label rather than any visible content modification.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, signaling a minor release of the page. This update does not alter the study’s data or displayed information.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page footer version was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a site/update release rather than a change to the clinical trial information presented.SummaryDifference0.0%

- Check68 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2. This appears to be a system-level update with no visible changes to study content or layout.SummaryDifference0.0%

- Check97 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC
Enter your email address, and we'll notify you when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.